Loading…
Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma
Abstract Background In patients with esophageal squamous cell carcinoma (ESCC), accurately predicting a pathologic complete response (pCR) to preoperative chemoradiotherapy (PCRT) has the potential to enable an active surveillance strategy without esophagectomy. We aimed to establish a reliable mult...
Saved in:
Published in: | Gastroenterology report 2024-07, Vol.12, p.goae060 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c310t-49c064050df94db53234fe77bb7171f8fdccb560e0f230c74e37f5651d1500083 |
container_end_page | |
container_issue | |
container_start_page | goae060 |
container_title | Gastroenterology report |
container_volume | 12 |
creator | Shin, Young Seob Jang, Jeong Yun Yoo, Ye Jin Yu, Jesang Song, Kye Jin Jo, Yoon Young Kim, Sung-Bae Park, Sook Ryun Song, Ho June Kim, Yong-Hee Kim, Hyeong Ryul Kim, Jong Hoon |
description | Abstract
Background
In patients with esophageal squamous cell carcinoma (ESCC), accurately predicting a pathologic complete response (pCR) to preoperative chemoradiotherapy (PCRT) has the potential to enable an active surveillance strategy without esophagectomy. We aimed to establish a reliable multiparameter nomogram model that combines tumor characteristics, imaging modalities, and hematologic markers to predict pCR in patients with ESCC who underwent PCRT and esophagectomy.
Methods
We retrospectively reviewed the medical records of 457 patients with ESCC who received PCRT followed by esophagectomy between January 2005 and October 2020. The nomogram model was developed using logistic regression analysis with a training cohort and externally validated with a validation cohort.
Results
In the training and validation cohorts, 44.2% (126/285) and 48.3% (83/172) of patients, respectively, achieved pCR after PCRT. The 5-year rates of overall survival, progression-free survival, and freedom from local progression in the training cohort were 51.6%, 48.5%, and 77.6%, respectively. The parameters included in the nomogram were histologic grade, clinical N stage, maximum standardized uptake value on positron emission tomography, and post-PCRT biopsy. Hematologic markers were significantly associated with survival outcomes but not with pCR. The area under the receiver operating characteristic curve of the nomogram was 0.717, 0.704, and 0.707 for the training cohort, internal validation cohort, and external validation cohort, respectively.
Conclusion
Our nomogram model based on four parameters obtained from standard clinical practice demonstrated good performance in both the training and validation cohorts and could be useful to aid clinical decision-making to determine whether surgery or active surveillance strategy should be pursued. |
doi_str_mv | 10.1093/gastro/goae060 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11227365</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/gastro/goae060</oup_id><sourcerecordid>3076765078</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-49c064050df94db53234fe77bb7171f8fdccb560e0f230c74e37f5651d1500083</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhiMEolXplSPyEQ7bjuM4zp4QqgpFquDSni3HmSRGcca1nVZ9DN6YbHepyomTLfvzNzP-i-I9hzMOW3E-mJQjnQ9kEGp4VRyXIMsNgKhev9gfFacp_QIADqqUXL4tjkSzVVWjmuPi9w_yNETjWU-RhYids9nNAwsmjzTR4Cyz5MOEGVnEFGhOuLLTRA9PWEQKGE1298jsiJ6i6RzlcT0Lj8zNO5HDOSf24PLIMFEYzYBmYuluMZ6WxCxOE7MmWjeTN--KN72ZEp4e1pPi9uvlzcXV5vrnt-8XX643VnDIm2proa5AQtdvq66VohRVj0q1reKK903fWdvKGhD6UoBVFQrVy1ryjsv1LxpxUnzee8PSeuzs2mM0kw7ReRMfNRmn_72Z3agHutecl6UStVwNHw-GSHcLpqy9S7thzIzrXFqAqlUtQe2Kne1RGymliP1zHQ56l6XeZ6kPWa4PPrzs7hn_m9wKfNoDtIT_yf4AO8Gwzg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3076765078</pqid></control><display><type>article</type><title>Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma</title><source>Open Access: PubMed Central</source><source>Open Access: Oxford University Press Open Journals</source><creator>Shin, Young Seob ; Jang, Jeong Yun ; Yoo, Ye Jin ; Yu, Jesang ; Song, Kye Jin ; Jo, Yoon Young ; Kim, Sung-Bae ; Park, Sook Ryun ; Song, Ho June ; Kim, Yong-Hee ; Kim, Hyeong Ryul ; Kim, Jong Hoon</creator><creatorcontrib>Shin, Young Seob ; Jang, Jeong Yun ; Yoo, Ye Jin ; Yu, Jesang ; Song, Kye Jin ; Jo, Yoon Young ; Kim, Sung-Bae ; Park, Sook Ryun ; Song, Ho June ; Kim, Yong-Hee ; Kim, Hyeong Ryul ; Kim, Jong Hoon</creatorcontrib><description>Abstract
Background
In patients with esophageal squamous cell carcinoma (ESCC), accurately predicting a pathologic complete response (pCR) to preoperative chemoradiotherapy (PCRT) has the potential to enable an active surveillance strategy without esophagectomy. We aimed to establish a reliable multiparameter nomogram model that combines tumor characteristics, imaging modalities, and hematologic markers to predict pCR in patients with ESCC who underwent PCRT and esophagectomy.
Methods
We retrospectively reviewed the medical records of 457 patients with ESCC who received PCRT followed by esophagectomy between January 2005 and October 2020. The nomogram model was developed using logistic regression analysis with a training cohort and externally validated with a validation cohort.
Results
In the training and validation cohorts, 44.2% (126/285) and 48.3% (83/172) of patients, respectively, achieved pCR after PCRT. The 5-year rates of overall survival, progression-free survival, and freedom from local progression in the training cohort were 51.6%, 48.5%, and 77.6%, respectively. The parameters included in the nomogram were histologic grade, clinical N stage, maximum standardized uptake value on positron emission tomography, and post-PCRT biopsy. Hematologic markers were significantly associated with survival outcomes but not with pCR. The area under the receiver operating characteristic curve of the nomogram was 0.717, 0.704, and 0.707 for the training cohort, internal validation cohort, and external validation cohort, respectively.
Conclusion
Our nomogram model based on four parameters obtained from standard clinical practice demonstrated good performance in both the training and validation cohorts and could be useful to aid clinical decision-making to determine whether surgery or active surveillance strategy should be pursued.</description><identifier>ISSN: 2052-0034</identifier><identifier>EISSN: 2052-0034</identifier><identifier>DOI: 10.1093/gastro/goae060</identifier><identifier>PMID: 38974878</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Original</subject><ispartof>Gastroenterology report, 2024-07, Vol.12, p.goae060</ispartof><rights>The Author(s) 2024. Published by Oxford University Press and Sixth Affiliated Hospital of Sun Yat-sen University 2024</rights><rights>The Author(s) 2024. Published by Oxford University Press and Sixth Affiliated Hospital of Sun Yat-sen University.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c310t-49c064050df94db53234fe77bb7171f8fdccb560e0f230c74e37f5651d1500083</cites><orcidid>0000-0002-5544-9492 ; 0000-0003-2177-4876</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227365/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227365/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,1604,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38974878$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shin, Young Seob</creatorcontrib><creatorcontrib>Jang, Jeong Yun</creatorcontrib><creatorcontrib>Yoo, Ye Jin</creatorcontrib><creatorcontrib>Yu, Jesang</creatorcontrib><creatorcontrib>Song, Kye Jin</creatorcontrib><creatorcontrib>Jo, Yoon Young</creatorcontrib><creatorcontrib>Kim, Sung-Bae</creatorcontrib><creatorcontrib>Park, Sook Ryun</creatorcontrib><creatorcontrib>Song, Ho June</creatorcontrib><creatorcontrib>Kim, Yong-Hee</creatorcontrib><creatorcontrib>Kim, Hyeong Ryul</creatorcontrib><creatorcontrib>Kim, Jong Hoon</creatorcontrib><title>Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma</title><title>Gastroenterology report</title><addtitle>Gastroenterol Rep (Oxf)</addtitle><description>Abstract
Background
In patients with esophageal squamous cell carcinoma (ESCC), accurately predicting a pathologic complete response (pCR) to preoperative chemoradiotherapy (PCRT) has the potential to enable an active surveillance strategy without esophagectomy. We aimed to establish a reliable multiparameter nomogram model that combines tumor characteristics, imaging modalities, and hematologic markers to predict pCR in patients with ESCC who underwent PCRT and esophagectomy.
Methods
We retrospectively reviewed the medical records of 457 patients with ESCC who received PCRT followed by esophagectomy between January 2005 and October 2020. The nomogram model was developed using logistic regression analysis with a training cohort and externally validated with a validation cohort.
Results
In the training and validation cohorts, 44.2% (126/285) and 48.3% (83/172) of patients, respectively, achieved pCR after PCRT. The 5-year rates of overall survival, progression-free survival, and freedom from local progression in the training cohort were 51.6%, 48.5%, and 77.6%, respectively. The parameters included in the nomogram were histologic grade, clinical N stage, maximum standardized uptake value on positron emission tomography, and post-PCRT biopsy. Hematologic markers were significantly associated with survival outcomes but not with pCR. The area under the receiver operating characteristic curve of the nomogram was 0.717, 0.704, and 0.707 for the training cohort, internal validation cohort, and external validation cohort, respectively.
Conclusion
Our nomogram model based on four parameters obtained from standard clinical practice demonstrated good performance in both the training and validation cohorts and could be useful to aid clinical decision-making to determine whether surgery or active surveillance strategy should be pursued.</description><subject>Original</subject><issn>2052-0034</issn><issn>2052-0034</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNqFkcFu1DAQhiMEolXplSPyEQ7bjuM4zp4QqgpFquDSni3HmSRGcca1nVZ9DN6YbHepyomTLfvzNzP-i-I9hzMOW3E-mJQjnQ9kEGp4VRyXIMsNgKhev9gfFacp_QIADqqUXL4tjkSzVVWjmuPi9w_yNETjWU-RhYids9nNAwsmjzTR4Cyz5MOEGVnEFGhOuLLTRA9PWEQKGE1298jsiJ6i6RzlcT0Lj8zNO5HDOSf24PLIMFEYzYBmYuluMZ6WxCxOE7MmWjeTN--KN72ZEp4e1pPi9uvlzcXV5vrnt-8XX643VnDIm2proa5AQtdvq66VohRVj0q1reKK903fWdvKGhD6UoBVFQrVy1ryjsv1LxpxUnzee8PSeuzs2mM0kw7ReRMfNRmn_72Z3agHutecl6UStVwNHw-GSHcLpqy9S7thzIzrXFqAqlUtQe2Kne1RGymliP1zHQ56l6XeZ6kPWa4PPrzs7hn_m9wKfNoDtIT_yf4AO8Gwzg</recordid><startdate>20240706</startdate><enddate>20240706</enddate><creator>Shin, Young Seob</creator><creator>Jang, Jeong Yun</creator><creator>Yoo, Ye Jin</creator><creator>Yu, Jesang</creator><creator>Song, Kye Jin</creator><creator>Jo, Yoon Young</creator><creator>Kim, Sung-Bae</creator><creator>Park, Sook Ryun</creator><creator>Song, Ho June</creator><creator>Kim, Yong-Hee</creator><creator>Kim, Hyeong Ryul</creator><creator>Kim, Jong Hoon</creator><general>Oxford University Press</general><scope>TOX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5544-9492</orcidid><orcidid>https://orcid.org/0000-0003-2177-4876</orcidid></search><sort><creationdate>20240706</creationdate><title>Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma</title><author>Shin, Young Seob ; Jang, Jeong Yun ; Yoo, Ye Jin ; Yu, Jesang ; Song, Kye Jin ; Jo, Yoon Young ; Kim, Sung-Bae ; Park, Sook Ryun ; Song, Ho June ; Kim, Yong-Hee ; Kim, Hyeong Ryul ; Kim, Jong Hoon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-49c064050df94db53234fe77bb7171f8fdccb560e0f230c74e37f5651d1500083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shin, Young Seob</creatorcontrib><creatorcontrib>Jang, Jeong Yun</creatorcontrib><creatorcontrib>Yoo, Ye Jin</creatorcontrib><creatorcontrib>Yu, Jesang</creatorcontrib><creatorcontrib>Song, Kye Jin</creatorcontrib><creatorcontrib>Jo, Yoon Young</creatorcontrib><creatorcontrib>Kim, Sung-Bae</creatorcontrib><creatorcontrib>Park, Sook Ryun</creatorcontrib><creatorcontrib>Song, Ho June</creatorcontrib><creatorcontrib>Kim, Yong-Hee</creatorcontrib><creatorcontrib>Kim, Hyeong Ryul</creatorcontrib><creatorcontrib>Kim, Jong Hoon</creatorcontrib><collection>Open Access: Oxford University Press Open Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Gastroenterology report</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shin, Young Seob</au><au>Jang, Jeong Yun</au><au>Yoo, Ye Jin</au><au>Yu, Jesang</au><au>Song, Kye Jin</au><au>Jo, Yoon Young</au><au>Kim, Sung-Bae</au><au>Park, Sook Ryun</au><au>Song, Ho June</au><au>Kim, Yong-Hee</au><au>Kim, Hyeong Ryul</au><au>Kim, Jong Hoon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma</atitle><jtitle>Gastroenterology report</jtitle><addtitle>Gastroenterol Rep (Oxf)</addtitle><date>2024-07-06</date><risdate>2024</risdate><volume>12</volume><spage>goae060</spage><pages>goae060-</pages><issn>2052-0034</issn><eissn>2052-0034</eissn><abstract>Abstract
Background
In patients with esophageal squamous cell carcinoma (ESCC), accurately predicting a pathologic complete response (pCR) to preoperative chemoradiotherapy (PCRT) has the potential to enable an active surveillance strategy without esophagectomy. We aimed to establish a reliable multiparameter nomogram model that combines tumor characteristics, imaging modalities, and hematologic markers to predict pCR in patients with ESCC who underwent PCRT and esophagectomy.
Methods
We retrospectively reviewed the medical records of 457 patients with ESCC who received PCRT followed by esophagectomy between January 2005 and October 2020. The nomogram model was developed using logistic regression analysis with a training cohort and externally validated with a validation cohort.
Results
In the training and validation cohorts, 44.2% (126/285) and 48.3% (83/172) of patients, respectively, achieved pCR after PCRT. The 5-year rates of overall survival, progression-free survival, and freedom from local progression in the training cohort were 51.6%, 48.5%, and 77.6%, respectively. The parameters included in the nomogram were histologic grade, clinical N stage, maximum standardized uptake value on positron emission tomography, and post-PCRT biopsy. Hematologic markers were significantly associated with survival outcomes but not with pCR. The area under the receiver operating characteristic curve of the nomogram was 0.717, 0.704, and 0.707 for the training cohort, internal validation cohort, and external validation cohort, respectively.
Conclusion
Our nomogram model based on four parameters obtained from standard clinical practice demonstrated good performance in both the training and validation cohorts and could be useful to aid clinical decision-making to determine whether surgery or active surveillance strategy should be pursued.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>38974878</pmid><doi>10.1093/gastro/goae060</doi><orcidid>https://orcid.org/0000-0002-5544-9492</orcidid><orcidid>https://orcid.org/0000-0003-2177-4876</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2052-0034 |
ispartof | Gastroenterology report, 2024-07, Vol.12, p.goae060 |
issn | 2052-0034 2052-0034 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11227365 |
source | Open Access: PubMed Central; Open Access: Oxford University Press Open Journals |
subjects | Original |
title | Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T23%3A19%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nomogram%20for%20predicting%20pathologic%20complete%20response%20following%20preoperative%20chemoradiotherapy%20in%20patients%20with%20esophageal%20squamous%20cell%20carcinoma&rft.jtitle=Gastroenterology%20report&rft.au=Shin,%20Young%20Seob&rft.date=2024-07-06&rft.volume=12&rft.spage=goae060&rft.pages=goae060-&rft.issn=2052-0034&rft.eissn=2052-0034&rft_id=info:doi/10.1093/gastro/goae060&rft_dat=%3Cproquest_pubme%3E3076765078%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c310t-49c064050df94db53234fe77bb7171f8fdccb560e0f230c74e37f5651d1500083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3076765078&rft_id=info:pmid/38974878&rft_oup_id=10.1093/gastro/goae060&rfr_iscdi=true |